Two Sigma Securities LLC Has $142,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Two Sigma Securities LLC trimmed its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 77.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,273 shares of the pharmacy operator's stock after selling 52,102 shares during the quarter. Two Sigma Securities LLC's holdings in Walgreens Boots Alliance were worth $142,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of WBA. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock worth $805,506,000 after buying an additional 2,279,495 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Walgreens Boots Alliance by 8.8% in the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after buying an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC lifted its position in Walgreens Boots Alliance by 5.2% during the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after buying an additional 1,020,587 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after acquiring an additional 2,185,950 shares during the last quarter. Finally, Norges Bank bought a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $58,241,000. 58.59% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina bought 832,258 shares of the firm's stock in a transaction dated Sunday, April 27th. The shares were bought at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. This trade represents a 0.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Stock Up 0.2 %

Shares of WBA stock traded up $0.02 during trading on Monday, reaching $11.00. The company's stock had a trading volume of 5,885,054 shares, compared to its average volume of 21,037,605. The business has a fifty day moving average price of $10.97 and a 200-day moving average price of $10.26. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $18.83. The company has a market cap of $9.51 billion, a price-to-earnings ratio of -1.07, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.20 EPS. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research report on Monday, January 13th. StockNews.com assumed coverage on Walgreens Boots Alliance in a report on Monday. They issued a "hold" rating for the company. Bank of America boosted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.